Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02716025

Enrollment

Registered

2016-03-22

Start date

2013-10-31

Completion date

2015-08-31

Last updated

2016-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic Ulcer Disease

Brief summary

Fifty consecutive patients with symptoms suggestive of peptic ulcer disease were included. All underwent complete clinical evaluation, laboratory investigations, upper gastrointestinal endoscopy and rapid urease test. Measurement of serum zinc level was done for all the included patients in addition to twenty five age and sex matched healthy control subjects.

Interventions

PROCEDUREUpper gastrointestinal endoscopy

Thorough examination of the esophagus, stomach and duodenum to the second part was done to all patients using Olympus CV-150 or Pentax EPM-3500.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Inclusion criteria

* Symptoms suggestive of peptic ulcer disease like epigastric pain, dyspepsia, heartburn

Exclusion criteria

* Patients who received zinc supplementation, proton pump inhibitors (PPI), non-steroidal anti-inflammatory drugs (NSAIDs) * Those presented with hematemesis or melena * Those with chronic liver disease, renal failure, malabsorption or previous gastric surgery

Design outcomes

Primary

Measure	Time frame
Detection of positive upper GIT endoscopic findings	upon endoscopy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026